Jump Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.19M Buy
58,740
+40,378
+220% +$5.65M 0.11% 209
2025
Q4
$2.25M Sell
18,362
-31,522
-63% -$3.83M 0.03% 628
2025
Q3
$5.54M Sell
49,884
-13,145
-21% -$1.49M 0.07% 371
2025
Q2
$6.99M Buy
+63,029
New +$6.71M 0.08% 323
2025
Q1
Sell
-12,833
Closed -$1.19M 1746
2024
Q4
$1.19M Sell
12,833
-5,093
-28% -$459K 0.02% 688
2024
Q3
$1.5M Sell
17,926
-49,274
-73% -$3.76M 0.03% 629
2024
Q2
$4.61M Sell
67,200
-30,061
-31% -$2.01M 0.09% 254
2024
Q1
$7.12M Buy
97,261
+90,113
+1,261% +$6.93M 0.19% 79
2023
Q4
$579K Buy
7,148
+4,184
+141% +$326K 0.02% 975
2023
Q3
$222K Buy
+2,964
New +$228K 0.01% 1458
2022
Q4
Sell
-121,664
Closed -$7.51M 1738
2022
Q3
$7.51M Buy
121,664
+112,475
+1,224% +$7.09M 0.29% 26
2022
Q2
$567K Sell
9,189
-32,585
-78% -$2.02M 0.02% 799
2022
Q1
$2.48M Buy
41,774
+28,912
+225% +$1.85M 0.11% 238
2021
Q4
$934K Sell
12,862
-32,582
-72% -$2.24M 0.06% 414
2021
Q3
$3.17M Buy
45,444
+22,482
+98% +$1.58M 0.23% 41
2021
Q2
$1.58M Buy
22,962
+12,056
+111% +$805K 0.15% 165
2021
Q1
$705K Buy
+10,906
New +$703K 0.07% 314

Other funds holding GILD

Jump Financial's GILD Position: Q1 2026 in Review

Jump Financial increased its Gilead Sciences (GILD) stake by 220% in Q1 2026, buying an estimated $5.65M and bringing the position to 58,740 shares worth $8.19M. The position accounts for 0.11% of the portfolio, ranked #209.

Jump Financial first reported a position in GILD in Q1 2021 and has held it in 17 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jump Financial held 58,740 shares of Gilead Sciences worth $8.19M as of Q1 2026.
  • Jump Financial bought 40,378 Gilead Sciences shares in Q1 2026, an estimated $5.65M.
  • Gilead Sciences made up 0.11% of Jump Financial's portfolio in Q1 2026, its #209 holding.
  • Jump Financial first reported a position in Gilead Sciences in Q1 2021 and has held it in 17 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.